Antiviral compounds composed of three linked Aryl moieties to treat diseases such as Hepatitis C

Details for Australian Patent Application No. 2010253791 (hide)

Owner Schering Corporation

Inventors Zeng, Qingbei; Chen, Kevin X.; Anilkumar, Gopinadhan N.; Rosenblum, Stuart B.; Kozlowski, Joseph A.; Njoroge, F. George

Agent Spruson & Ferguson

Pub. Number AU-A-2010253791

PCT Pub. Number WO2010/138791

Priority 61/182,401 29.05.09 US

Filing date 28 May 2010

Wipo publication date 2 December 2010

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4184 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/138791 Priority application(s): WO2010/138791

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010253797-Peptoid ligands for isolation and treatment of autoimmune T-cells

2010253790-Antiviral compounds composed of three aligned aryl moieties to treat diseases such as Hepatitis C